Peter Reichertz
FTC Targets Reporting of Licensing of Pharmaceutical Patents With Special Rules for Premerger Notification: What You Need to Know
Antitrust, Competition and Trade ·
A Short-Lived Victory for Generic Manufacturers? – Part 2
Business and Commercial ·
No Avoiding BPCIA For Biosimilars: No Patent Declaratory Judgment Action Before Biosimilars Application Is Filed
Health Care and Life Sciences ·
FDA’s Draft Guidance For Industry On Pre-Launch Activities Importation Requests: Dead On Arrival?
Food, Drug & Agriculture ·
A Short-Lived Victory for Generic Drug Manufacturers?
Food, Drug & Agriculture ·